Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Accelerated Tissue Processing With Minimal Formalin Fixation Time for 9-Gauge Vacuum-Assisted Breast Biopsy Specimens.

Bulte JP, Halilovic A, Burgers LJM, Diepenbroek CJM, de la Roij RAK, Mann RM, van der Leest M, van Cleef PHJ, Strobbe LJA, de Wilt JHW, Bult P.

Am J Clin Pathol. 2019 Aug 15. pii: aqz111. doi: 10.1093/ajcp/aqz111. [Epub ahead of print]

PMID:
31415692
2.

HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study.

Halilovic A, Verweij DI, Simons A, Stevens-Kroef MJPL, Vermeulen S, Elsink J, Tops BBJ, Otte-Höller I, van der Laak JAWM, van de Water C, Boelens OBA, Schlooz-Vries MS, Dijkstra JR, Nagtegaal ID, Tol J, van Cleef PHJ, Span PN, Bult P.

Sci Rep. 2019 Aug 12;9(1):11679. doi: 10.1038/s41598-019-48212-2.

3.

The molecular genetic make-up of male breast cancer.

Moelans CB, de Ligt J, van der Groep P, Prins P, Besselink N, Hoogstraat M, Ter Hoeve N, Lacle M, Kornegoor R, van der Pol C, de Leng W, Barbe E, van der Vegt B, Martens J, Bult P, Smits VT, Koudijs M, Nijman I, Voest E, Selenica P, Weigelt B, Reis-Filho J, van der Wall E, Cuppen E, van Diest PJ.

Endocr Relat Cancer. 2019 Jul 1. pii: ERC-19-0278. doi: 10.1530/ERC-19-0278. [Epub ahead of print]

PMID:
31340200
4.

Deep learning assisted mitotic counting for breast cancer.

Balkenhol MCA, Tellez D, Vreuls W, Clahsen PC, Pinckaers H, Ciompi F, Bult P, van der Laak JAWM.

Lab Invest. 2019 Jun 20. doi: 10.1038/s41374-019-0275-0. [Epub ahead of print]

PMID:
31222166
5.

A systematic review on the use of the breast lesion excision system in breast disease.

Sanderink WBG, Laarhuis BI, Strobbe LJA, Sechopoulos I, Bult P, Karssemeijer N, Mann RM.

Insights Imaging. 2019 May 2;10(1):49. doi: 10.1186/s13244-019-0737-3. Review.

6.

Measuring the depth of invasion in vulvar squamous cell carcinoma: interobserver agreement and pitfalls.

Pouwer AW, Bult P, Otte I, van der Brand M, van der Horst J, Harterink LJV, van de Vijver KK, Guerra E, Aliredjo RP, Bosch SL, M M Grefte J, Zomer S, Hollema H, de Heus B, Satumalaij S, Ewing-Graham PC, IntHout J, de Hullu JA, Bulten J.

Histopathology. 2019 Sep;75(3):413-420. doi: 10.1111/his.13883. Epub 2019 Jul 26.

PMID:
31021414
7.

Deep learning and manual assessment show that the absolute mitotic count does not contain prognostic information in triple negative breast cancer.

Balkenhol MCA, Bult P, Tellez D, Vreuls W, Clahsen PC, Ciompi F, van der Laak JAWM.

Cell Oncol (Dordr). 2019 Aug;42(4):555-569. doi: 10.1007/s13402-019-00445-z. Epub 2019 Apr 15.

PMID:
30989469
8.

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer.

van Uden DJP, van Maaren MC, Bult P, Strobbe LJA, van der Hoeven JJM, Blanken-Peeters CFJM, Siesling S, de Wilt JHW.

Breast Cancer Res Treat. 2019 Jul;176(1):217-226. doi: 10.1007/s10549-019-05219-7. Epub 2019 Apr 10.

9.

Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.

Vreemann S, Dalmis MU, Bult P, Karssemeijer N, Broeders MJM, Gubern-Mérida A, Mann RM.

Eur Radiol. 2019 Sep;29(9):4678-4690. doi: 10.1007/s00330-019-06020-2. Epub 2019 Feb 22.

10.

From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 Challenge.

Bandi P, Geessink O, Manson Q, Van Dijk M, Balkenhol M, Hermsen M, Ehteshami Bejnordi B, Lee B, Paeng K, Zhong A, Li Q, Zanjani FG, Zinger S, Fukuta K, Komura D, Ovtcharov V, Cheng S, Zeng S, Thagaard J, Dahl AB, Lin H, Chen H, Jacobsson L, Hedlund M, Cetin M, Halici E, Jackson H, Chen R, Both F, Franke J, Kusters-Vandevelde H, Vreuls W, Bult P, van Ginneken B, van der Laak J, Litjens G.

IEEE Trans Med Imaging. 2019 Feb;38(2):550-560. doi: 10.1109/TMI.2018.2867350.

PMID:
30716025
11.

Artificial Intelligence-Based Classification of Breast Lesions Imaged With a Multiparametric Breast MRI Protocol With Ultrafast DCE-MRI, T2, and DWI.

Dalmiş MU, Gubern-Mérida A, Vreemann S, Bult P, Karssemeijer N, Mann R, Teuwen J.

Invest Radiol. 2019 Jun;54(6):325-332. doi: 10.1097/RLI.0000000000000544.

PMID:
30652985
12.

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.

Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, Gubern-Mérida A, Mann RM.

Breast Cancer Res. 2018 Aug 3;20(1):84. doi: 10.1186/s13058-018-1019-6.

13.

Intravital microscopy of collective invasion plasticity in breast cancer.

Ilina O, Campanello L, Gritsenko PG, Vullings M, Wang C, Bult P, Losert W, Friedl P.

Dis Model Mech. 2018 Aug 23;11(9). pii: dmm034330. doi: 10.1242/dmm.034330.

14.

Whole-Slide Mitosis Detection in H&E Breast Histology Using PHH3 as a Reference to Train Distilled Stain-Invariant Convolutional Networks.

Tellez D, Balkenhol M, Otte-Holler I, van de Loo R, Vogels R, Bult P, Wauters C, Vreuls W, Mol S, Karssemeijer N, Litjens G, van der Laak J, Ciompi F.

IEEE Trans Med Imaging. 2018 Mar 28. doi: 10.1109/TMI.2018.2820199. [Epub ahead of print]

PMID:
29994086
15.

1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset.

Litjens G, Bandi P, Ehteshami Bejnordi B, Geessink O, Balkenhol M, Bult P, Halilovic A, Hermsen M, van de Loo R, Vogels R, Manson QF, Stathonikos N, Baidoshvili A, van Diest P, Wauters C, van Dijk M, van der Laak J.

Gigascience. 2018 Jun 1;7(6). doi: 10.1093/gigascience/giy065.

16.

Vulvar cancer: Two pathways with different localization and prognosis.

Hinten F, Molijn A, Eckhardt L, Massuger LFAG, Quint W, Bult P, Bulten J, Melchers WJG, de Hullu JA.

Gynecol Oncol. 2018 May;149(2):310-317. doi: 10.1016/j.ygyno.2018.03.003. Epub 2018 Mar 16.

PMID:
29555332
17.

Assessment of HER2 status in breast cancer biopsies is not affected by accelerated tissue processing.

Bulte JP, Halilovic A, Kalkman S, van Cleef PHJ, van Diest PJ, Strobbe LJA, de Wilt JHW, Bult P.

Histopathology. 2018 Jul;73(1):81-89. doi: 10.1111/his.13507. Epub 2018 Apr 24.

PMID:
29495112
18.

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.

Severson TM, Kim Y, Joosten SEP, Schuurman K, van der Groep P, Moelans CB, Ter Hoeve ND, Manson QF, Martens JW, van Deurzen CHM, Barbe E, Hedenfalk I, Bult P, Smit VTHBM, Linn SC, van Diest PJ, Wessels L, Zwart W.

Nat Commun. 2018 Feb 2;9(1):482. doi: 10.1038/s41467-018-02856-2.

19.

The frequency of missed breast cancers in women participating in a high-risk MRI screening program.

Vreemann S, Gubern-Merida A, Lardenoije S, Bult P, Karssemeijer N, Pinker K, Mann RM.

Breast Cancer Res Treat. 2018 Jun;169(2):323-331. doi: 10.1007/s10549-018-4688-z. Epub 2018 Jan 31.

20.

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.

Vreemann S, Gubern-Mérida A, Borelli C, Bult P, Karssemeijer N, Mann RM.

PLoS One. 2018 Jan 19;13(1):e0191399. doi: 10.1371/journal.pone.0191399. eCollection 2018.

Supplemental Content

Loading ...
Support Center